RUNX2 and breast cancer: Li et al. identified ITGA5 as a novel transcriptional target of RUNX2 and demonstrated that RUNX2 fosters the recruitment and colonization of breast cancer cells in bone via ITGA5-dependent mechanisms, culminating in bone metastasis [164].